Related Experiment Video
Updated: Jun 6, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
QSAR modelling of bioconcentration factor using hydrophobicity, hydrogen bonding and topological descriptors
1School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK. j.c.dearden@ljmu.ac.uk
Abstract:
Bioconcentration factor (BCF) is an important step in the uptake of environmental pollutants in the food chain. It is expensive and time-consuming to measure, so predictive methods are of value. We have used an artificial neural network QSAR approach involving descriptors for hydrophobicity, hydrogen bonding and molecular topology, obtained from commercially available software, to predict the fish BCF values of a diverse data set of 624 chemicals. The training set statistics were: r²= 0.765, q²= 0.763, s = 0.610, and those of the external test set were: r²= 0.739, s = 0.627. The model complies with the OECD Principles for the Validation of (Q)SARs.
More Related Videos
Related Concept Videos
Noncovalent Attractions in Biomolecules
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Pharmacodynamic Models: Linear Concentration–Effect Model

